New York State Assembly

 
•  Summary 
 
•  Actions 
 
•  Committee Votes 
 
•  Floor Votes 
 
•  Memo 
 
•  Text 
 
•  LFIN 
 
•  Chamber Video/Transcript 

A06506 Summary:

A06506 Actions:

A06506 Committee Votes:

Committee:CONSUMER AFFAIRS AND PROTECTION   Chair:Rozic      
DATE:05/16/2023AYE/NAY:15/0  Action: Favorable refer to committee Codes        
Rozic
Aye
Mikulin
Aye
Fall
Excused
Miller
Aye
Burgos
Aye
Blumencranz
Aye
Gallagher
Aye
Beephan
Aye
Rajkumar
Aye
Maher
Aye
Forrest
Aye
Wallace
Aye
Bores
Aye
Lee
Aye
Alvarez
Aye
Simone
Aye

Committee:CODES   Chair:Dinowitz      
DATE:05/23/2023AYE/NAY:20/0  Action: Favorable refer to committee Rules        
Dinowitz
Aye
Morinello
Aye
Pretlow
Aye
Reilly
Aye
Cook
Absent
Mikulin
Aye
O'Donnell
Aye
Tannousis
Aye
Lavine
Aye
Curran
Aye
Weprin
Aye
Angelino
Aye
Hevesi
Aye
Flood
Aye
Seawright
Aye
Rosenthal
Aye
Walker
Excused
Vanel
Aye
Cruz
Aye
Carroll
Aye
Simon
Aye
Epstein
Aye

Committee:RULES   Chair:Pretlow      
DATE:05/30/2023AYE/NAY:29/0  Action: Favorable         
Heastie
Excused
Barclay
Aye
Weinstein
Aye
Hawley
Aye
Pretlow
Aye
Giglio
Aye
Cook
Aye
Blankenbush
Aye
Glick
Aye
Norris
Aye
Aubry
Aye
Ra
Aye
Dinowitz
Aye
Brabenec
Aye
Colton
Aye
Palmesano
Aye
Magnarelli
Aye
Reilly
Aye
Paulin
Aye
Peoples-Stokes
Aye
Benedetto
Aye
Lavine
Aye
Lupardo
Aye
Zebrowski
Aye
Thiele
Aye
Braunstein
Aye
Dickens
Aye
Davila
Aye
Hyndman
Aye
Rozic
Excused
Bronson
Aye

A06506 Floor Votes:

A06506 Text:

 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         6506--B
                                                                Cal. No. 186
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                     April 12, 2023
                                       ___________
 
        Introduced  by  M.  of  A.  TAPIA,  ZACCARO,  ALVAREZ, LAVINE, RAJKUMAR,
          DE LOS SANTOS, SIMONE, REYES, SOLAGES, DICKENS, RIVERA, RAMOS, ARDILA,
          BUTTENSCHON, FORREST, SHIMSKY, LUCAS, CUNNINGHAM, CRUZ, SIMON, SAYEGH,
          EPSTEIN,  BICHOTTE HERMELYN,  BORES,  TANNOUSIS,   REILLY,   K. BROWN,
          BLUMENCRANZ,  CHANG,  J. A. GIGLIO,  PIROZZOLO, DeSTEFANO -- read once
          and referred to the Committee on Consumer Affairs  and  Protection  --
          reported   and  referred  to  the  Committee  on  Codes  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee -- ordered to a third reading -- advanced to a third
          reading, passed by Assembly and delivered to the Senate, recalled from
          the  Senate,  vote  reconsidered,  bill  amended,  ordered  reprinted,
          retaining its place on the order of third reading
 
        AN ACT to amend the general business law, in relation to prohibiting the
          sale of xylazine
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The general business law is amended by adding a new section
     2  392-k to read as follows:
     3    § 392-k. Sale of xylazine. 1. For purposes of this section,  the  term
     4  "xylazine"  shall  mean  a  pharmaceutical drug used for sedation, anes-
     5  thesia, muscle relaxation, and analgesia  in  animals  such  as  horses,
     6  cattle, and other non-human mammals.
     7    2.  No  corporation,  partnership,  limited  liability  company, firm,
     8  online platform, or any other business entity doing business within this
     9  state shall knowingly sell, offer for sale, or deliver xylazine to indi-
    10  viduals without proof of its intended use for institutional, veterinary,
    11  or scientific purposes.
    12    3. No  corporation,  partnership,  limited  liability  company,  firm,
    13  online  platform,  or  other  business entity doing business within this
    14  state shall knowingly sell, offer for sale, or deliver xylazine to indi-
    15  viduals under the age of twenty-one.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10463-07-4
        A. 6506--B                          2
 
     1    4. Any corporation,  partnership,  limited  liability  company,  firm,
     2  online  platform  or  other  business  entity doing business within this
     3  state which knowingly sells, offers for sale, or  distributes  xylazine,
     4  shall  require  and retain sales records, proof of age, and proof of use
     5  from all purchasers.
     6    5.  Any  corporation,  partnership,  limited  liability company, firm,
     7  online platform, or other business entity  doing  business  within  this
     8  state that violates the provisions of this section by knowingly selling,
     9  offering  for  sale,  or delivering xylazine shall be subject to a civil
    10  penalty of not more than three thousand dollars for a  first  violation,
    11  and  sixty-five hundred dollars for each subsequent violation, recovera-
    12  ble in an action by the attorney general of the state of New York.   All
    13  funds  collected  or  received by the state from civil penalties imposed
    14  under this section shall be deposited in the New York state drug  treat-
    15  ment  and  public education fund established pursuant to section ninety-
    16  nine-jj of the state finance law.
    17    § 2. This act shall take effect immediately.